↓ Skip to main content

Dove Medical Press

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to…

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, February 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
67 Mendeley
Title
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
Published in
International Journal of Chronic Obstructive Pulmonary Disease, February 2012
DOI 10.2147/copd.s27320
Pubmed ID
Authors

Dennis E Doherty, Donald P Tashkin, Edward Kerwin, Barbara A Knorr, Tulin Shekar, Sibabrata Banerjee, Heribert Staudinger

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Australia 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 16%
Researcher 10 15%
Student > Bachelor 10 15%
Other 7 10%
Student > Doctoral Student 4 6%
Other 12 18%
Unknown 13 19%
Readers by discipline Count As %
Medicine and Dentistry 39 58%
Biochemistry, Genetics and Molecular Biology 4 6%
Nursing and Health Professions 2 3%
Agricultural and Biological Sciences 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 5 7%
Unknown 13 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#8,535,472
of 25,374,917 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#1,053
of 2,577 outputs
Outputs of similar age
#74,735
of 253,528 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#6
of 16 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,528 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.